000			01383 a2200433 4500
005			20250511205848.0
264		0	_c19911127
008			199111s 0 0 fre d
022			_a0755-4982
040			_aNLM _beng _cNLM
100	1		_aFortier, B
245	0	0	_a[Prevention and treatment of materno-fetal toxoplasmosis]. _h[electronic resource]
260			_bPresse medicale (Paris, France : 1983) _cSep 1991
300			_a1374-83 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAdult
650	0	4	_aFemale
650	0	4	_aFood Contamination _xprevention & control
650	0	4	_aHumans
650	0	4	_aImmunoglobulin A _xanalysis
650	0	4	_aImmunoglobulin G _xanalysis
650	0	4	_aImmunoglobulin M _xanalysis
650	0	4	_aInfant, Newborn
650	0	4	_aMale
650	0	4	_aMaternal-Fetal Exchange
650	0	4	_aPregnancy
650	0	4	_aPrenatal Diagnosis
650	0	4	_aPyrimethamine _xtherapeutic use
650	0	4	_aSerologic Tests
650	0	4	_aSpiramycin _xtherapeutic use
650	0	4	_aSulfanilamides _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aToxoplasmosis, Congenital _xdrug therapy
700	1		_aAjana, F
700	1		_aPinto de Sousa, M I
700	1		_aAissi, E
700	1		_aCamus, D
773	0		_tPresse medicale (Paris, France : 1983) _gvol. 20 _gno. 29 _gp. 1374-83
999			_c1841215 _d1841215